Safety and immunogenicity of a modified pox vector-based HIV/AIDS vaccine candidate expressing Env, Gag, Pol and Nef proteins of HIV-1 subtype B (MVA-B) in healthy HIV-1-uninfected volunteers: A phase I clinical trial (RISVAC02).
Details
Serval ID
serval:BIB_A19B2FD68BEA
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Safety and immunogenicity of a modified pox vector-based HIV/AIDS vaccine candidate expressing Env, Gag, Pol and Nef proteins of HIV-1 subtype B (MVA-B) in healthy HIV-1-uninfected volunteers: A phase I clinical trial (RISVAC02).
Journal
Vaccine
ISSN
1873-2518 (Electronic)
ISSN-L
0264-410X
Publication state
Published
Issued date
2011
Volume
29
Number
46
Pages
8309-8316
Language
english
Notes
Publication types: Journal ArticlePublication Status: ppublish
Pubmed
Web of science
Create date
08/11/2011 17:30
Last modification date
20/08/2019 16:07